http://orcid.org/0000-0002-9425-1526
References
- Khan AT, Shehmar M, Gupta JK. (2014). Uterine fibroids: current perspectives. Int J Women Health 6:95–114.
- Kim YS, Rhim H, Choi MJ, et al. (2008). High-intensity focused ultrasound therapy: an overview for radiologists. Korean J Radiol 9:291–302.
- Zhang L, Chen WZ, Liu YJ, et al. (2010). Feasibility of magnetic resonance imaging-guided high intensity focused ultrasound therapy for ablating uterine fibroids in patients with bowel lies anterior to uterus. Eur J Radiol 73:396–403.
- Kim HS, Baik JH, Pham LD, Jacobs MA. (2011). MR-guided high-intensity focused ultrasound treatment for symptomatic uterine leiomyomata: long-term outcomes. Acad Radiol 18:970–6.
- Wang W, Wang Y, Tang J. (2009). Safety and efficacy of high intensity focused ultrasound ablation therapy for adenomyosis. Acad Radiol 16:1416–23.
- Zhou XD, Ren XL, Zhang J, et al. (2007). Therapeutic response assessment of high intensity focused ultrasound therapy for uterine fibroid: utility of contrast-enhanced ultrasonography. Eur J Radiol 62:289–94.
- Luo W, Zhou X, Tian X, et al. (2006). Enhancement of ultrasound contrast agent in high-intensity focused ultrasound ablation. Adv Ther 23:861–8.
- Orsi F, Monfardini L, Bonomo G, et al. (2015). Ultrasound guided high intensity focused ultrasound (USgHIFU) ablation for uterine fibroids: do we need the microbubbles? Int J Hypertherm 31:233–9.
- Peng S, Xiong Y, Li K, et al. (2012). Clinical utility of a microbubble-enhancing contrast (“SonoVue”) in treatment of uterine fibroids with high intensity focused ultrasound: a retrospective study. Eur J Radiol 81:3832–8.
- Schneider M. (1999). Characteristics of SonoVuetrade mark. Echocardiography 16:743–6.
- Orsini LF, Salardi S, Pilu G, et al. (1984). Pelvic organs in premenarcheal girls: real-time ultrasonography. Radiology 153:113–6.
- Ferrara KW, Borden MA, Zhang H. (2009). Lipid-shelled vehicles: engineering for ultrasound molecular imaging and drug delivery. Acc Chem Res 42:881–92.
- Luo W, Zhou X, Ren X, et al. (2007). Enhancing effects of SonoVue, a microbubble sonographic contrast agent, on high-intensity focused ultrasound ablation in rabbit livers in vivo. J Ultrasound Med 26:469–76.
- Jiang N, Xie B, Zhang X, et al. (2014). Enhancing ablation effects of a microbubble-enhancing contrast agent (“SonoVue”) in the treatment of uterine fibroids with high-intensity focused ultrasound: a randomized controlled trial). Cardiovasc Intervent Radiol 37:1321–8.
- Piscaglia F, Bolondi L. (2006). The safety of SonoVue in abdominal applications: retrospective analysis of 23188 investigations. Ultrasound Med Biol 32:1369–75.